Caffeine and adenosine.
Caffeine causes most of its biological effects via antagonizing all types of adenosine receptors (ARs): A1, A2A, A3, and A2B and, as does adenosine, exerts effects on neurons and glial cells of all brain areas. In consequence, caffeine, when acting as an AR antagonist, is doing the opposite of activation ... of adenosine receptors due to removal of endogenous adenosinergic tonus. Besides AR antagonism, xanthines, including caffeine, have other biological actions: they inhibit phosphodiesterases (PDEs) (e.g., PDE1, PDE4, PDE5), promote calcium release from intracellular stores, and interfere with GABA-A receptors. Caffeine, through antagonism of ARs, affects brain functions such as sleep, cognition, learning, and memory, and modifies brain dysfunctions and diseases: Alzheimer's disease, Parkinson's disease, Huntington's disease, Epilepsy, Pain/Migraine, Depression, Schizophrenia. In conclusion, targeting approaches that involve ARs will enhance the possibilities to correct brain dysfunctions, via the universally consumed substance that is caffeine.
Mesh Terms:
Adenosine, Animals, Caffeine, Cognition, Humans, Learning, Mental Disorders, Models, Biological, Nervous System Diseases, Phosphodiesterase Inhibitors, Purinergic P1 Receptor Antagonists, Receptors, Purinergic P1
Adenosine, Animals, Caffeine, Cognition, Humans, Learning, Mental Disorders, Models, Biological, Nervous System Diseases, Phosphodiesterase Inhibitors, Purinergic P1 Receptor Antagonists, Receptors, Purinergic P1
J. Alzheimers Dis.
Date: Feb. 19, 2010
PubMed ID: 20164566
View in: Pubmed Google Scholar
Download Curated Data For This Publication
174341
Switch View:
- Chemical Interactions 21